Skip to main content

Smith + Nephew Plc Value Stock - Dividend - Research Selection

Smith and nephew

ISIN: GB0009223206 , WKN: 502816

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Smith & Nephew plc designs, develops, and sells medical devices worldwide. The company offers sports medicine joint repair products for surgeons, including an array of instruments, technologies, and implants necessary to perform minimally invasive surgery of the joints, such as the repair of soft tissue injuries and degenerative conditions of the knee, hip, and shoulder. It also provides arthroscopic enabling technologies for healthcare providers comprising fluid management equipment for surgical access, high definition cameras, digital image capture, scopes, light sources, and monitors to assist with visualization inside the joints, radio frequency, electromechanical and mechanical tissue resection devices, and hand instruments for removing damaged tissue. In addition, the company offers trauma and extremities products that include internal and external devices used in the stabilization of severe fractures and deformity correction procedures; robotics-assisted surgery, various products, and technologies to assist in surgical treatment of the ear, nose, and throat; knee implant products for specialized knee replacement procedures; and hip implant products for the reconstruction of hip joints. Further, it provides advanced wound care products for the treatment and prevention of acute and chronic wounds, which comprise leg, diabetic and pressure ulcers, burns, and post-operative wounds; advanced wound bioactives, including biologics and other bioactive technologies for debridement and dermal repair/regeneration; and advanced wound devices, such as traditional and single-use negative pressure wound therapy and hydrosurgery systems. The company primarily serves the providers of medical and surgical treatments and services. Smith & Nephew plc was founded in 1856 and is headquartered in London, the United Kingdom.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Bernstein Cuts PT on Smith & Nephew plc (SNN)

2026-05-26
Smith & Nephew plc (NYSE:SNN) is one of the best robotic surgery stocks to buy. Bernstein cut the price target on Smith & Nephew plc (NYSE:SNN) to $31.85 from $36.20 on May 11, maintaining a Market Perform rating on the shares. The rating update came after the company provided a fiscal Q1 trading update on May […]

[Latest] Global Orthopedic Soft Tissue Repair Market Size/Share Worth USD 15.38 Billion by 2035 at a 9.6 CAGR: Healthcare Foresights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

2026-05-18
[220+ Pages Latest Report] According to a market research study published by Healthcare Foresights, the demand analysis of Global Orthopedic Soft Tissue Repair Market size & share revenue was valued at approximately USD 7.26 Billion in 2025 and is expected to reach USD 7.96 Billion in 2026 and is expected to reach around USD 15.38 Billion by 2035, at a CAGR of 9.6 between 2026 and 2035. The key market players listed in the report with their sales, revenues and strategies are Arthrex Inc., Stryke

Medical Device Stocks Are Ready to Bounce. Two Names to Buy Now.

2026-05-13
Glaukos, a medical technology company focusing on eye disorders, has achieved gains of 20% year to date and 48% over the last year.

VEEV Boosts MedTech Quality Management With Smith+Nephew Partnership

2026-05-13
Veeva Systems expands its medtech reach as Smith+Nephew adopts Veeva Quality Cloud to modernize global quality operations and training.

Tennessee's top export is not whiskey or country music, it's this

2026-05-13
Whiskey and country music may be synonymous with Tennessee, but they aren't what the state ships the most of.

Smith & Nephew and Four More Stocks See Action From Activist Investors

2026-05-08
13D FILINGS These disclosures are from 13Ds filed with the Securities and Exchange Commission. 13Ds are filed within 10 days of an entity’s attaining more than 5% in any class of a company’s securities.

Smith & Nephew plc (SNN) Q1 2026 Sales/Trading Call Transcript

2026-05-06
Smith & Nephew plc (SNN) Q1 2026 Sales/Trading Call May 6, 2026 3:30 AM EDTCompany ParticipantsDeepak Nath - CEO & DirectorJohn Rogers - CFO &...

FTSE 100 Live: Fresnillo and Rolls lead soaring stocks as US 'close to' Iran deal

2026-05-06
FTSE 100 up 265 points to 10,484 Trump pauses 'Project Freedom' in Strait to focus on Iran talks US officials believe deal with Iran is close UK services PMI improves, but costs spike Diageo, Next, Wetherspoon, Smith & Nephew and Reach report updates 12.49pm: Stocks on a...

Smith & Nephew plc (SNN) Q1 2026 Sales/ Trading Statement Call - Slideshow

2026-05-06
2026-05-06. The following slide deck was published by Smith & Nephew plc in conjunction with this event.

Smith+Nephew drives progress in chronic wound care with ALLEVYN™COMPLETE CARE Dressing and RENASYS™ EDGE tNPWT set to launch at EWMA 2026

2026-05-05
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, continues to drive progress in chronic wound management with an industry-leading portfolio set to showcase at the upcoming European Wound Management Association (EWMA) Conference, Bremen between 6-8 May 2026. Demonstrating a long-term commitment to chronic wound management, Smith+Nephew is launching two new wound care innovations designed to support patient outcomes, simplify wound management and ease the clinical burden. Th